Nalaganje...
LAMA/LABA vs ICS/LABA in the treatment of COPD in Japan based on the disease phenotypes
In the combined use of bronchodilators of different classes, ie, long-acting β(2)-agonists (LABAs) and long-acting muscarinic antagonists (LAMAs), bronchodilation is obtained both directly, through LABA-mediated stimulation of β(2)-adrenergic receptors, and indirectly, through LAMA-mediated inhibiti...
Shranjeno v:
| izdano v: | Int J Chron Obstruct Pulmon Dis |
|---|---|
| Glavni avtor: | |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Dove Medical Press
2015
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4468951/ https://ncbi.nlm.nih.gov/pubmed/26089659 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/COPD.S72858 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|